MedLRN · Live webinar series · Level 7-aligned CPD

The Paediatric ADHD Series

Assessment to shared care — six live, case-based webinars with a Consultant Child & Adolescent Psychiatrist.

Cohort starts Saturday 15 August 2026

Six live, case-based webinars — assessment to shared care.

From the first Conners score to the shared-care agreement: every session is anchored to a fully-worked patient case, grounded in NICE NG87 and DSM-5-TR, with protected live Q&A time with the specialist.

6 × 60-min live sessions Fortnightly Saturdays, 2–3 pm UK CPD certificate per session Recordings included
Early-bird — ends Sat 1 Aug
£29.99 / webinar £39.99

Full six-part series: £149 £239.94
Every live seat, every recording, every worksheet.

Reserve your place

Prices include VAT · Places limited for live Q&A
See the full curriculum

Live webinars, fortnightly
hrs
Certificated live CPD
Fully-worked patient cases
Competency frameworks you self-rate against

ADHD demand is outrunning the workforce

Referrals are at record levels, waiting lists are years long, and shared care is pushing prescribing and monitoring decisions into primary care, community pharmacy and non-medical prescribing. Most prescribers were never trained for it.

The tools mislead the untrained

A "very elevated" Conners score is where the assessment starts — not where it ends. Scales carry bias, miss girls, and can't establish onset, pervasiveness or impairment. You'll learn what each tool can and cannot tell you.

Real cases, not textbook ones

Every session is anchored to a fully-worked case with the complete multi-informant dossier on the table — rating scales, school reports, sleep diaries, physical obs — exactly what you'd be holding in clinic.

Defensible, guideline-anchored practice

Every decision is traced back to NICE NG87 and DSM-5-TR — and you'll map your own practice against the RPS prescribing framework and the NSW ADHD competency standard.

A scale can raise a question. It can't answer one.

See how the series works

A minute from the series lead on what you'll learn — and a taste of how the live cases run.

Welcome to the Paediatric ADHD Series — video

Welcome to the Paediatric ADHD Series — series introduction · 1 min

Inside a live case — the Amara case video

Inside a live case — the Amara case · 1 min

Six sessions. The whole pathway.

Fortnightly Saturdays, 2–3 pm UK. Each session pairs focused teaching with a fully-worked case you reason through live — then a specialist's synthesis of the answer.

Session 1 Sat 15 Aug 2–3 pm UK · 60 min · Live on Zoom

Diagnosing ADHD in Children & Adolescents

The tools, the red flags, and when to refer — an honest critique of the diagnostic toolbox.

  • NICE NG87 criteria and the DSM-5 symptom domains
  • Conners 3, SDQ, ADHD-RS-5, SNAP-IV — and what they can't do
  • Differential diagnosis: the mimics, from anxiety to ASD to SLD
  • Red flags: when to pause, rethink or escalate
  • Referral thresholds and the primary-care boundary (NG87 1.2.9)
  • Self-rate against the RPS and NSW prescribing competency frameworks

Case: Amara, 14 — a very elevated Conners, and a switch that flipped in Year 9. Is the inattention primary?

Session 2 Sat 29 Aug 2–3 pm UK · 60 min · Live on Zoom

First-Line Prescribing Decisions

Stimulants and non-stimulants in paediatric populations — choosing, and justifying the choice.

  • Methylphenidate, lisdexamfetamine, atomoxetine, guanfacine — where each fits
  • Age, comorbidity and formulation in agent choice
  • The pre-prescribing baseline: cardiac history, growth, tics
  • When NG87 requires an ECG and cardiology opinion first (1.7.5–1.7.6)
  • Shared decision-making with an anxious family
  • Documenting a defensible prescribing rationale

Case: Leo, 9 — secure diagnosis, a family history of sudden cardiac death, mild tics and a 9th-centile weight. How do you start?

Session 3 Sat 12 Sep 2–3 pm UK · 60 min · Live on Zoom

Titration in Children & Adolescents

Dose escalation, test-dose strategy, preparation switches and response monitoring.

  • Start low, review weekly: structuring the titration window
  • Test-dose strategy and defining target symptoms with school
  • Immediate-release vs modified-release; switching preparations
  • Measuring response: baselines, scales and teacher feedback
  • Managing early adverse effects without losing the family
  • When titration stalls: optimise, switch or step back

Case: Leo, part 2 — cardiology has cleared him. Build the titration and review schedule you'd actually document.

Session 4 Sat 26 Sep 2–3 pm UK · 60 min · Live on Zoom

Monitoring & Safety

Growth, cardiovascular, sleep, appetite, mood and tics — and knowing when the answer is "no".

  • The NG87 monitoring schedule: BP, HR, height and weight, plotted
  • Growth faltering and appetite suppression — thresholds for action
  • Sleep, mood and tic surveillance at every review
  • Planned drug holidays and deprescribing conversations
  • When physical obs forbid a dose increase
  • Safeguarding and risk: what can't wait for the next routine review

Case: Reuben, 13 — stable for years, now deteriorating. The family want the dose increased. The obs say otherwise.

Session 5 Sat 10 Oct 2–3 pm UK · 60 min · Live on Zoom

Comorbidity & Complex Cases

ADHD with autism, anxiety, ODD, tics and sleep disorders — untangling state from trait.

  • Comorbidity is the rule: reformulate before you re-dose
  • ADHD vs ASD: is all hyperactivity the same?
  • ADHD vs anxiety, mood disorders and OCD — the discriminators
  • Prescribing adaptations in autism: start low, titrate slowly
  • Guanfacine, atomoxetine and the tic/anxiety picture
  • Diagnostic overshadowing — in both directions

Case: Idris, 8 — autistic, "never still", and calmest when he knows what's next. ADHD — or is the autism doing the work?

Session 6 Sat 24 Oct 2–3 pm UK · 60 min · Live on Zoom

Transition & Shared Care

The 16–18 transition, shared-care agreements, and communicating across CAMHS and primary care.

  • The CAMHS-to-adult-services cliff edge — and how patients fall off it
  • NG87 on transition planning: start early, involve the young person
  • Shared-care agreements: who does what, and what you must not accept
  • Monitoring responsibilities after stabilisation (NG87 1.7.29)
  • Writing to CAMHS and GPs so the plan survives the handover
  • Where your competence sits on the pathway — and your next CPD step

Case: Jordan, 16 — stable on treatment, exams next year, and a transition plan nobody has started.

Built for adult learners, not lectures

You won't sit through 60 minutes of slides. Each session follows a tested rhythm that makes you commit to a position before the specialist reveals theirs — because that's where the learning happens.

  1. 1
    5 min

    Warm-up

    Rapid MCQs or a private self-rating poll — locate yourself honestly before we start.

  2. 2
    20 min

    The teaching

    Focused, critical, guideline-anchored — what the tools and guidelines actually say.

  3. 3
    20 min

    The case

    Full informant dossier on screen. You reflect, commit to a position, and share your reasoning.

  4. 4
    5 min

    The synthesis

    The consultant's answer — what was decisive, and why the tempting answer was wrong.

  5. 5
    10 min

    Q&A

    Protected time for your questions, live. Nothing pre-recorded, nothing scripted.

Every session, everything you need to act on it

  • Live seat + protected Q&AAsk the consultant directly — every session ends with dedicated question time.
  • Full recording accessCan't make a date? Every session is recorded and available on the MedLRN platform.
  • CPD certificate per sessionOne certificated hour per webinar — six across the series — for your revalidation portfolio.
  • Case worksheets & reflection templatesTake-away worksheets designed to double as CPD portfolio evidence.
  • The competency frameworksThe RPS prescribing framework and NSW ADHD competency standard, to self-rate against.
  • Slide summaries & referencesKey-slide handouts with the full NG87 / DSM-5-TR reference map.

Learn from a practising specialist

Dr Chhitij Srivastava, Consultant Child & Adolescent Psychiatrist
Your presenter

Dr Chhitij Srivastava

Consultant Child & Adolescent Psychiatrist · current NHS ADHD caseload

MD DNB MRCPsych CCT (Child & Adolescent Psychiatry) 6+ years of clinical webinars

A clinician and academic specialising in the assessment and management of ADHD and neurodevelopmental conditions in children and young people — the diagnostic and prescribing perspective in every session comes from live specialist practice, not theory.

Dr Srivastava built this series around the questions prescribers actually bring: the ambiguous scores, the mixed pictures, and the cases where the guideline answer isn't obvious.

Made for the prescribing front line

This series is for you if you are…

  • A pharmacist independent prescriber moving into ADHD or mental health
  • A GP or practice-based prescriber holding shared-care patients
  • A nurse prescriber or ANP in CAMHS, paediatrics or primary care
  • A MedLRN ADHD Diploma candidate wanting the live, case-based layer
  • Any clinician who wants to reason through real ADHD cases with a specialist

It is not…

  • A sign-off that you are competent to diagnose or prescribe — an hour cannot build a competency (NG87 1.3.1)
  • A substitute for formal training and supervised practice
  • A scoring workshop for the rating scales — that's your CPD; we show you what the scores mean
  • A passive lecture series — you'll be asked to commit to positions and defend them

Book a session — or take the whole pathway

Early-bird pricing ends Saturday 1 August. Prices include VAT.

Single webinar

Pick the sessions you need

£29.99 / session £39.99

Early-bird — save £10 per session

  • Live 60-minute session + Q&A
  • Recording access
  • CPD certificate (1 hour)
  • Session worksheet & slide summary

Booking for a team of three or more? Invoice payment is available — email contact@medlrn.co.uk and we'll set it up.

Questions, answered

Will this qualify me to diagnose or prescribe for ADHD?

No — and be wary of anything that says otherwise. Diagnosis is a specialist act (NG87 1.3.1) and competence is built through formal training and supervised practice. This series does what good CPD should: it sharpens your reasoning on real cases, shows you honestly where your gaps are against recognised competency frameworks, and gives you a clear map for your next development step. Each session carries a CPD certificate for your portfolio.

What if I can't make a live date?

Every session is recorded and made available on the MedLRN platform, so a clash never costs you the content. That said, the live sessions are where the value concentrates — the polls, the case discussion and the Q&A are interactive, and the specialist responds to the room.

Do I need to attend all six?

No — each session stands alone and you can book individually. But the series is built as a pathway: the case you meet in session 2 returns in session 3, and the reasoning compounds. The full-series bundle exists because that's how we'd recommend taking it — and it saves you £90.

Who is the series pitched at?

Prescribers and clinicians who work with — or are moving toward — children and young people with ADHD: pharmacist independent prescribers, GPs, nurse prescribers and ANPs, and MedLRN ADHD Diploma candidates. The material is pitched at Level 7: you'll be handling full multi-informant dossiers, not simplified vignettes.

How is this different from the MedLRN ADHD Diploma?

The Diploma is a structured Level 7 qualification with assessed units. This webinar series is the live, case-based layer: it maps to the Diploma's units and frameworks, works standalone as certificated CPD, and is the best way to experience how we teach before committing to the full Diploma.

How do I pay, and can my employer book for a team?

Card payment at checkout. For team bookings (three or more), invoice payment is available — contact contact@medlrn.co.uk and we'll set it up.

Cohort starts Sat 15 Aug · Early-bird pricing ends Saturday 1 August

Reason like a specialist.
Prescribe with confidence.

Six webinars. Six worked cases. One complete pathway.

This series supports reflection and continuing professional development. It does not certify competence to diagnose or prescribe (NICE NG87 1.3.1). All patient cases are fictional composites created for educational discussion and do not constitute clinical or prescribing advice.